share_log

Landos Biopharma | PREM14A: Preliminary proxy statements relating to merger or acquisition

SEC announcement ·  Apr 15 17:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more